The Executive Exchange Series (EES)
Building interconnectivity builds an industry
UPCOMING ees EVENTS
Recent ees Events
On November 27th, OBIO held its 9th Annual Public Meeting at offices of Norton Rose Fulbright. It was an exciting event with a formidable Keynote, a packed room of industry leaders, and an excellent venue for networking!
Regulatory and Business Strategy
Joel Ironstone is a medical technology development expert with over 15 years of consulting experience developing novel medical technologies. His experience includes technical development, regulatory approvals and the design and execution of clinical trials.
Presented by Bausch + Lomb
Bausch + Lomb is a subsidiary division of the multinational specialty pharmaceutical company, Valeant Pharmaceuticals International, located in Quebec, Canada. B+L operates within the health care and optics space, with a major focus on marketing, sales and distribution of vision care products.
Looking for the latest funding programs or a valuable partnership? Go beyond combing websites and come to OBIO's “Meet the Non-Dilutive Money!”
Representatives will be Live & In Person from:
- Ontario Centres of Excellence (OCE)
- Ontario Genomics Institute (OGI)
OBIO’s ½ day workshop on health economics, in partnership with and hosted by St. Michael’s Hospital Toronto, will include the following topics:
- The role of payors in healthcare technology adoption in major jurisdictions
- Understanding, designing and executing trials to show product value
- Pricing and market access strategies driven by Health Economics
OBIO® invites you to a unique opportunity to hear Andrew Hutchinson of Alexion Pharmaceuticals, a global pharmaceutical company, provide his valuable insights on best practices for approaching strategic partners in the pharmaceutical industry. Andrew is an External Research & Scouting Lead and is focused on the search, identification and evaluation of business development opportunities for Alexion Pharmaceuticals.